Tech Company Financing Transactions
TriNetX Funding Round
TriNetX, based in Cambridge, scored $40 million from Merck Global Health Innovation Fund, Deerfield Capital and F2 Ventures.
Transaction Overview
Company Name
Announced On
3/14/2019
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series D
Investors
Proceeds Purpose
The new financing will be used to accelerate the company's ongoing international expansion efforts in Europe, Asia and South America. The funding will also be used to further development of TriNetX's industry leading analytics platform, especially in the areas of artificial intelligence, machine learning and digital clinical trials.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
125 Cambridgepark Dr. 500
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Website
Email Address
Overview
When it comes to advancing healthcare, data drives everything. It powers clinical trials. It guides treatment options. It informs business decisions. And it can speed the way to market. That's why having access to practitioners and patients is so critical. And why data collection must be targeted, streamlined and productive.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gadi Lachman
Chief Medical Officer
Manfred Stapff
Chief Technical Officer
Steve Kundrot
Vice President
Steve Lethbridge
VP - Bus. Development
Brian Flaherty
VP - Bus. Development
Maulik Mehta
VP - Finance
Chris Fraser
VP - Marketing
Jennifer Haas
Browse more venture capital transactions:
Prev: 3/14/2019: LaunchDarkly venture capital transaction
Next: 3/14/2019: Stash venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs